Abstract
Evidence suggests that patient gender is associated with the quality of care provided in the treatment of cardiometabolic diseases. The majority of findings suggest that female patients receive less intensified care than male patients. However, the question whether physician gender plays a role in the quality of care has been debated for some time. For example, it has been postulated that the practice styles of female physicians, such as spending more time with a patient, hearing and listening more effectively, and including more preventive measures, may result in more efficient clinical encounters that may positively affect clinical outcomes. This narrative review examines the existing evidence regarding the effects of physician gender on the quality of care provided, focusing mainly on patients with cardiometabolic diseases.
Keywords: Physician gender, quality of care, cardiovascular disease, hypertension, diabetes mellitus, chronic heart failure, blood pressure, lipid control, cardiac catheterization, glycemic control
Current Pharmaceutical Design
Title: Role of Physician Gender in the Quality of Care of Cardiometabolic Diseases
Volume: 17 Issue: 33
Author(s): I. Gouni-Berthold and H. K. Berthold
Affiliation:
Keywords: Physician gender, quality of care, cardiovascular disease, hypertension, diabetes mellitus, chronic heart failure, blood pressure, lipid control, cardiac catheterization, glycemic control
Abstract: Evidence suggests that patient gender is associated with the quality of care provided in the treatment of cardiometabolic diseases. The majority of findings suggest that female patients receive less intensified care than male patients. However, the question whether physician gender plays a role in the quality of care has been debated for some time. For example, it has been postulated that the practice styles of female physicians, such as spending more time with a patient, hearing and listening more effectively, and including more preventive measures, may result in more efficient clinical encounters that may positively affect clinical outcomes. This narrative review examines the existing evidence regarding the effects of physician gender on the quality of care provided, focusing mainly on patients with cardiometabolic diseases.
Export Options
About this article
Cite this article as:
Gouni-Berthold I. and K. Berthold H., Role of Physician Gender in the Quality of Care of Cardiometabolic Diseases, Current Pharmaceutical Design 2011; 17 (33) . https://dx.doi.org/10.2174/138161211798220954
DOI https://dx.doi.org/10.2174/138161211798220954 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Treating COPD in Older and Oldest Old Patients
Current Pharmaceutical Design Cardiac Amyloidosis Responding to Bortezomib: Case Report and Review of Literature
Current Cardiology Reviews A Novel and Significant Method for Antioxidant Activity Utilizing Microtitre-plate (Resazurin Reducing Power Assay)
Current Chemical Biology Use of Metformin and Survival of Diabetic Women with Breast Cancer
Current Drug Safety Ghrelin in Obesity, Physiological and Pharmacological Considerations
Mini-Reviews in Medicinal Chemistry Cardiac Metabolism in Diabetes Mellitus
Current Pharmaceutical Design Nutrigenomics and Personalized Diet: What are the Anticipated Impacts for Research on Chronic Diseases and Public Health?
Current Pharmacogenomics and Personalized Medicine Lipoprotein(a) Management: Pharmacological and Apheretic Treatment
Current Medicinal Chemistry Pragmatic Analysis of Dyslipidemia Involvement in Coronary Artery Disease: A Narrative Review
Current Cardiology Reviews The Etiology of Hypertension in the Metabolic Syndrome Part Two: The Gene-Environment Interaction
Current Vascular Pharmacology Current Status of Rho-Associated Kinases (ROCKs) in Coronary Atherosclerosis and Vasospasm
Cardiovascular & Hematological Agents in Medicinal Chemistry A Review of Hypertension Management in Atrial Fibrillation
Current Hypertension Reviews Can Serum Uric Acid Lowering Therapy Contribute to the Prevention or Treatment of Nonalcoholic Fatty Liver Disease?
Current Vascular Pharmacology Imaging Subclinical Atherosclerosis: Where Do We Stand?
Current Cardiology Reviews Editorial: Exploring Lipid-related Treatment Options for the Treatment of NASH
Current Vascular Pharmacology The Coronary Circulation in Cyanotic Congenital Heart Disease
Current Cardiology Reviews New Strategy on Antimicrobial-resistance: Inhibitors of DNA Replication Enzymes
Current Medicinal Chemistry Evaluation and Management of Atrial Fibrillation
Cardiovascular & Hematological Disorders-Drug Targets Subject Index Volume 6
Mini-Reviews in Medicinal Chemistry Directions for Enhancement of the Therapeutic Efficacy of Mesenchymal Stem Cells in Different Neurodegenerative and Cardiovascular Diseases: Current Status and Future Perspectives
Current Stem Cell Research & Therapy